Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Wustite
1. Iron(ii) Oxide
2. Oxoiron
3. 1345-25-1
4. Iron Monooxide
5. Iron Monoxide
6. Iron(ii)oxide
7. Wustite
8. Natural Wuestite
9. Eisenoxydul
10. Iron-oxygen
11. Unii-g7036x8b5h
12. Hsdb 464
13. Eisen(ii)-oxid
14. Iron(2) Oxide
15. Einecs 215-721-8
16. Iron(2+) Oxide
17. Iron(ii) Oxide, Cp
18. Ec 215-721-8
19. Iron(2+);oxygen(2-)
20. Chebi:50820
21. Mfcd00016095
22. Akos015913785
23. 17125-56-3
24. Q196680
25. Iron(ii) Oxide, -10 Mesh, 99.8% Trace Metals Basis
| Molecular Weight | 71.84 g/mol |
|---|---|
| Molecular Formula | FeO |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 1 |
| Rotatable Bond Count | 0 |
| Exact Mass | 71.929850 g/mol |
| Monoisotopic Mass | 71.929850 g/mol |
| Topological Polar Surface Area | 17.1 Ų |
| Heavy Atom Count | 2 |
| Formal Charge | 0 |
| Complexity | 2 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Digital Content
DATA COMPILATION #PharmaFlow
ABOUT THIS PAGE
A Oxoiron manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oxoiron, including repackagers and relabelers. The FDA regulates Oxoiron manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oxoiron API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Oxoiron supplier is an individual or a company that provides Oxoiron active pharmaceutical ingredient (API) or Oxoiron finished formulations upon request. The Oxoiron suppliers may include Oxoiron API manufacturers, exporters, distributors and traders.
click here to find a list of Oxoiron suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Oxoiron DMF (Drug Master File) is a document detailing the whole manufacturing process of Oxoiron active pharmaceutical ingredient (API) in detail. Different forms of Oxoiron DMFs exist exist since differing nations have different regulations, such as Oxoiron USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Oxoiron DMF submitted to regulatory agencies in the US is known as a USDMF. Oxoiron USDMF includes data on Oxoiron's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Oxoiron USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Oxoiron suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Oxoiron Drug Master File in Japan (Oxoiron JDMF) empowers Oxoiron API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Oxoiron JDMF during the approval evaluation for pharmaceutical products. At the time of Oxoiron JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Oxoiron suppliers with JDMF on PharmaCompass.
Oxoiron Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Oxoiron GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Oxoiron GMP manufacturer or Oxoiron GMP API supplier for your needs.
A Oxoiron CoA (Certificate of Analysis) is a formal document that attests to Oxoiron's compliance with Oxoiron specifications and serves as a tool for batch-level quality control.
Oxoiron CoA mostly includes findings from lab analyses of a specific batch. For each Oxoiron CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Oxoiron may be tested according to a variety of international standards, such as European Pharmacopoeia (Oxoiron EP), Oxoiron JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oxoiron USP).
LOOKING FOR A SUPPLIER?
